ARGX
Price:
$663.93
Market Cap:
$41.84B
argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, thyroid eye disease, bullous pemphigoid, myositis, primary sjögren's syndrome, post-covid postural orthostatic tachycardia syndrome, membranous nephropathy, lupus nephropathy, anca-associated vasculitis, and antibody mediated rejection; ENHANZE SC; Empasiprubart for multifocal motor...[Read more]
Industry
Biotechnology
IPO Date
2017-05-18
Stock Exchange
NASDAQ
Ticker
ARGX
According to argenx SE’s latest financial reports and current stock price. The company's current Enterprise Value is 38.43B. This represents a change of 0.76% compared to the average of 38.14B of the last 4 quarters.
The mean historical Enterprise Value of argenx SE over the last ten years is 16.30B. The current 38.43B Enterprise Value has changed 23.47% with respect to the historical average. Over the past ten years (40 quarters), ARGX's Enterprise Value was at its highest in in the December 2025 quarter at 48.30B. The Enterprise Value was at its lowest in in the December 2013 quarter at -31373415.00.
Average
16.30B
Median
13.70B
Minimum
205.46M
Maximum
48.20B
Discovering the peaks and valleys of argenx SE Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 435.36%
Maximum Annual Enterprise Value = 48.20B
Minimum Annual Increase = 0%
Minimum Annual Enterprise Value = 205.46M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 48.20B | 23.31% |
| 2024 | 39.09B | 98.97% |
| 2023 | 19.64B | 0.86% |
| 2022 | 19.48B | 10.60% |
| 2021 | 17.61B | 80.02% |
| 2020 | 9.78B | 88.81% |
| 2019 | 5.18B | 88.83% |
| 2018 | 2.74B | 149.44% |
| 2017 | 1.10B | 435.36% |
| 2016 | 205.46M | 52.69% |
The current Enterprise Value of argenx SE (ARGX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
35.64B
5-year avg
28.80B
10-year avg
16.30B
argenx SE’s Enterprise Value is less than Becton, Dickinson and Company (74.36B), less than Edwards Lifesciences Corporation (45.68B), less than Alnylam Pharmaceuticals, Inc. (41.02B), greater than Veeva Systems Inc. (28.93B), less than Regeneron Pharmaceuticals, Inc. (75.73B), less than Cardinal Health, Inc. (55.16B), greater than Agilent Technologies, Inc. (33.08B), less than Haleon plc (40.72B), less than IDEXX Laboratories, Inc. (46.99B), less than Alcon Inc. (39.62B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 74.36B | $55.84B | |
| 45.68B | $47.92B | |
| 41.02B | $41.40B | |
| 28.93B | $30.26B | |
| 75.73B | $76.15B | |
| 55.16B | $48.91B | |
| 33.08B | $31.48B | |
| 40.72B | $44.84B | |
| 46.99B | $46.09B | |
| 39.62B | $35.90B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like argenx SE using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like argenx SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is argenx SE's Enterprise Value?
What is the highest Enterprise Value for argenx SE (ARGX)?
What is the 3-year average Enterprise Value for argenx SE (ARGX)?
What is the 5-year average Enterprise Value for argenx SE (ARGX)?
How does the current Enterprise Value for argenx SE (ARGX) compare to its historical average?